Table 1. Breast cancer tumour characteristics of women with cosmetic silicone breast implants prior to cancer diagnosis (cases) and breast cancer cases from the background population (controls).
Cases (n=23) |
Controls (n=253) |
||||
---|---|---|---|---|---|
Characteristic of woman or tumour | n | % | n | % | OR (95% CI)a |
Tumour histology (WHO) | |||||
Ductal | 16 | 70 | 212 | 84 | 0.5 (0.2–1.6)b |
Lobular | 5 | 22 | 18 | 7 | P=0.26 |
Other | 0 | 0 | 18 | 7 | |
Unknown | 2 | 9 | 5 | 2 | |
Tumour hormone-receptor status | |||||
Negative | 6 | 26 | 52 | 21 | 1.7 (0.6–4.9) |
Positive | 10 | 43 | 148 | 59 | P=0.32 |
Unknown | 7 | 30 | 53 | 21 | |
Tumour diameter (mm) (mean, range) | 20.5 | Range 9–50 | 25.2 | Range 3–110 | P=0.48 |
Unknown | 3 | 13 | 10 | 4 | |
Ductal carcinomas, malignancy grade (dedifferentiation) | |||||
Grade I | 6 | 26 | 52 | 21 | 1.7 (0.6–5.0)c |
Grade II | 9 | 39 | 110 | 43 | P=0.31 |
Grade III | 1 | 4 | 40 | 16 | |
Nonductal or unknown | 7 | 30 | 51 | 20 | |
Breast cancer operation | |||||
Mastectomy | 15 | 65 | 184 | 73 | 0.6 (0.3–1.6)d |
Lumpectomy | 6 | 26 | 60 | 24 | P=0.34 |
Lumpectomy followed by mastectomy | 0 | 0 | 4 | 2 | |
Biopsy only | 2 | 9 | 5 | 2 | |
Tumour cells in surgical margins (DBCG-data) | |||||
Yes | 7 | 30 | 24 | 9 | 4.2 (1.5–11.4) |
No | 14 | 61 | 201 | 79 | P=0.003 |
Unknown | 2 | 9 | 28 | 11 | |
Tumour cells in surgical margins (medical record information)e | |||||
Yes | 5 | 22 | 24 | 9 | 2.5 (0.8–7.3) |
No | 17 | 74 | 201 | 79 | P=0.09 |
Unknown | 1 | 4 | 28 | 11 | |
Axillary surgery | |||||
Five or less lymph nodes removed | 4 | 17 | 40 | 16 | 1.2 (0.4–3.6) |
More than five lymph nodes removed | 18 | 78 | 210 | 83 | P=0.79 |
Unknown | 1 | 4 | 3 | 1 | |
Mean number of lymph nodes removed | 11.4 | Range 0–32 | 11.3 | Range 0–31 | P=0.16 |
Axillary lymph node metastases | |||||
Node-negative | 11 | 48 | 130 | 51 | 0.9 (0.4–2.2) |
Node-positive | 11 | 48 | 120 | 47 | P=0.86 |
Unknown | 1 | 4 | 3 | 1 | |
Mean number of lymph nodes affected | 2.7 | Range 0–20 | 2.2 | Range 0–24 | P=0.10 |
Women with distant metastases at time of diagnosis | 1 | 4 | 4 | 2 | P=0.36 |
Women with implants (cases) compared with women from the background population (controls). Women with missing information with regard to the variable under study were excluded from the analysis.
Ductal carcinomas vs all other cancers.
Malignancy grade I vs malignancy grade II and III grouped together.
Mastectomy vs lumpectomy. In case of conversion from lumpectomy to mastectomy, the category was mastectomy. In cases of biopsy only, the category was lumpectomy.
Based on medical record information for 22 cases and 23 controls. For the remainder, the DBCG-data were used.